Compass Therapeutics, Inc. (CMPX) Sof foyda bo'yicha sotuv rentabelligi

Compass Therapeutics (CMPX) tovar belgisi

Compass Therapeutics hozirda barqaror foyda manbasiga ega bo'lmagan investitsiya loyihasi sifatida faoliyat yuritmoqda. Ushbu GURU.Markets grafigidagi tijorat sof marjasi joriy qiymat 0.00 ekanligini ko'rsatmoqda. O'sish istiqbollari safro yo'llari saratoniagainst CT-707 dori vositasining sinovlariga asoslangan. Muvaffaqiyat kuchli ilmiy tajribaga ega shaffof rahbarlik va malakali patent boshqaruvi bilan qo'llab-quvvatlanadi.

CMPX: Compass Therapeutics Corp Kompaniyaning sof rentabelligi 04.07.2022 - 19.11.2026

Compass Therapeutics kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:compasstherapeutics.com - CMPX
Compass Bio yetakchi tovari

Ilmiy institutlar bilan onkologik antitelalarni birgalikda ishlab chiqishga investitsiya kiritadigan Compass Therapeutics (CMPX) uchun operatsion xarajatlarni nazorat qilish juda muhimdir. Konsolidatsiyalashgan sof foyda marjasini tahlil qilish orqali investor daromadning har bir birligiga to'g'ri keladigan foyda ulushini aniqlaydi, bunda manfiy qiymatlar naqd pulning sarflanishi (cash burn) haqida signal beradi, bu esa ushbu ko'rsatkichni moliyaviy barqarorlikni va majburiy pozitsiyalarni yopish risklarini baholashning asosiy vositasiga aylantiradi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Replimune Inc.|Lyell Immunopharma (LYEL) - Sof marja|Innate Pharma S.A. - Sof foyda normasi|PYXS (Pyxis) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi cgen.com|Sof marja IO Biotech (IOBT)|STRO: Sof foyda marjasi|MiNK Therapeutics Inc. - Sof foyda bo'yicha sotuv rentabelligi|werewolftx.com (HOWL) - Sof marja|Immix Biopharma Inc. - Sotuvning sof marjinal rentabelligi|ALXO - Sotuvning sof marjinal rentabelligi|CUE: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi PDSB|Sof marja Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi LIMN|Sotuvning sof marjinal rentabelligi Lava Tx (LVTX)|Sotuvning sof marjinal rentabelligi NXTC (NextCure Corporation)|Sof foyda normasi LPTX|INTS - Sof marja|Kompaniya sotuv marjasi Sensei Biotherapeutics Inc SNSE|TOVX: Sotuvning sof marjinal rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)